Literature DB >> 21086086

Older persons with diabetes receive fewer inappropriate ICD shocks: results from the INTRINSIC RV trial.

Chirag M Sandesara1, Renee M Sullivan, Andrea M Russo, WeiWei Li, Arthur Kendig, John D Day, Christopher Mullin, Kira Stolen, Brian Olshansky.   

Abstract

In patients with heart disease, diabetes and age predict adverse outcomes. It remains unclear whether persons with diabetes who have implantable cardioverter defibrillators (ICDs) have fewer appropriate and inappropriate ICD shocks. The objective of this study is to determine if persons with diabetes who have ICDs receive a similar amount of appropriate and inappropriate shocks compared to persons without diabetes. In a post hoc analysis of 1,528 patients enrolled in the INTRINSIC RV trial, all-cause mortality and ICD shocks between persons with and without diabetes, stratified by age, was compared. The relationship between shock and mortality was also assessed. Mortality 1 year after ICD implant was lower for persons without diabetes vs. persons with diabetes (3.5% vs. 7.9%, p < 0.001). Young and old persons with diabetes received a similar number of total and appropriate ICD shocks. However, older persons with diabetes were less likely to receive inappropriate ICD shocks vs. older persons without diabetes (1.9% vs. 6.9%, p < 0.01). ICD shocks were not temporally related to mortality regardless of diabetes status. In the INTRINSIC RV trial, persons with diabetes and older persons without diabetes undergoing ICD implant were at a higher risk of death. Older persons with diabetes received less inappropriate shocks and still had a similar amount of appropriate shocks compared to persons without diabetes of similar age.

Entities:  

Mesh:

Year:  2010        PMID: 21086086     DOI: 10.1007/s12265-010-9236-0

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  20 in total

1.  Predictive value of preoperative left ventricular ejection fraction and functional class for mortality and morbidity after high-risk coronary artery bypass grafting.

Authors:  B Olshansky; E A Telfer; A B Curtis; J T Bigger
Journal:  Am J Cardiol       Date:  2000-06-15       Impact factor: 2.778

2.  Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from The CABG Patch Trial database. The CABG Patch Trial Investigators and Coordinators.

Authors:  W Whang; J T Bigger
Journal:  J Am Coll Cardiol       Date:  2000-10       Impact factor: 24.094

Review 3.  Antiarrhythmic effects of statins in heart failure.

Authors:  Chirag M Sandesara; Hamid Roodneshin; Salam Sbaity; Brian Olshansky
Journal:  Heart Fail Clin       Date:  2008-04       Impact factor: 3.179

4.  Reduction of right ventricular pacing in patients with dual-chamber ICDs.

Authors:  Brian Olshansky; John Day; Maureen McGuire; Stephen Hahn; Scott Brown; Darin R Lerew
Journal:  Pacing Clin Electrophysiol       Date:  2006-03       Impact factor: 1.976

5.  Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality.

Authors:  T Jared Bunch; John D Day; Brian Olshansky; Kira Q Stolen; Christopher M Mullin
Journal:  Heart Rhythm       Date:  2008-09-27       Impact factor: 6.343

6.  Prognostic importance of defibrillator shocks in patients with heart failure.

Authors:  Jeanne E Poole; George W Johnson; Anne S Hellkamp; Jill Anderson; David J Callans; Merritt H Raitt; Ramakota K Reddy; Francis E Marchlinski; Raymond Yee; Thomas Guarnieri; Mario Talajic; David J Wilber; Daniel P Fishbein; Douglas L Packer; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

7.  Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.

Authors:  Wayne C Levy; Kerry L Lee; Anne S Hellkamp; Jeanne E Poole; Dariush Mozaffarian; David T Linker; Aldo P Maggioni; Inder Anand; Philip A Poole-Wilson; Daniel P Fishbein; George Johnson; Jill Anderson; Daniel B Mark; Gust H Bardy
Journal:  Circulation       Date:  2009-08-24       Impact factor: 29.690

8.  Effect of cardiac and noncardiac conditions on survival after defibrillator implantation.

Authors:  Douglas S Lee; Jack V Tu; Peter C Austin; Paul Dorian; Raymond Yee; Alice Chong; David A Alter; Andreas Laupacis
Journal:  J Am Coll Cardiol       Date:  2007-06-11       Impact factor: 24.094

9.  Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005.

Authors:  Sarah Rosner Preis; Shih-Jen Hwang; Sean Coady; Michael J Pencina; Ralph B D'Agostino; Peter J Savage; Daniel Levy; Caroline S Fox
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

10.  Predictors of early mortality in implantable cardioverter-defibrillator recipients.

Authors:  Kenneth M Stein; Suneet Mittal; F Roosevelt Gilliam; David M Gilligan; Qian Zhong; Stacia Merkel Kraus; Timothy E Meyer
Journal:  Europace       Date:  2009-03-11       Impact factor: 5.214

View more
  2 in total

Review 1.  Implantable cardioverter defibrillators in diabetics: efficacy and safety in patients at risk of sudden cardiac death.

Authors:  Muhammad Shahreyar; Vijayadershan Mupiddi; Indrajit Choudhuri; Jasbir Sra; Abdul Jamil Tajik; Arshad Jahangir
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-06-22

Review 2.  Adverse events following implantable cardioverter defibrillator implantation: a systematic review.

Authors:  Rebecca Persson; Amy Earley; Ann C Garlitski; Ethan M Balk; Katrin Uhlig
Journal:  J Interv Card Electrophysiol       Date:  2014-06-20       Impact factor: 1.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.